Correlation of polymorphism of the coding region of glutathione S-transferase M1 to susceptibility of nasopharyngeal carcinoma in South China population

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 5-7

  He, Ying ^a   Zhou, Gang Qiao ^a,b,c   Li, Xin ^a   Dong, Xiao Jia ^a,b,c   Chai, Xian Qi ^a   Yao, Kai Tai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Genetic susceptibility; Glutathione S transferase M1 (GSTM1) gene; Glutathione S transferase polymorphism; Nasopharyngeal neoplasm

Indexed keywords

GLUTATHIONE TRANSFERASE M1;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENETIC CODE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67749103824     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Min HQ, Hong MH, Guo X. Nasopharyngeal carcinoma [M]. Beijing: Chinese Medical Science and Technology Publishing House, 2003: 12-25. [in Chinese]
2. Cheng YJ, Hildesheim A, Hsu MM, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan[J]. Cancer Causes Control, 1999,10(3):201-207
3. Friborg JT, Yuan JM, Wang R, et al. A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese[J]. Cancer, 2007,109(6):1183-1191
4. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance [J]. Crit Rev Biochem Mol Biol, 1995, 30(6): 445-600.
5. Lee E, Huang Y, Zhao B, et al. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2 [J]. J Toxicol Sci, 1998, 23(Suppl 2):140-142.
6. Xu S, Wang Y, Roe B, et al. Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion [J]. J Biol Chem, 1998, 273(6): 3517-3527.
7. He Y, Zhou G, Zhai Y, et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population [J]. J Med Genet, 2005; 42 (2):172-176.
8. Ye S, Dhillon S, Ke X, et al. An efficient procedure for genotyping single nucleotide polymorphisms[J]. Nucleic Acids Res, 2001, 29(17):E88-8.
9. Zhou G, Zhai Y, Dong X, et al. Variants in TNFRSF5 locus and association analysis with Hepatitis B virus (HBV) infection[J]. Hum Mutat, 2004, 23(1):99-100.
10. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease [J]. Nat Genet, 2003, 33(2): 177-182
11. Vistisen K, Priemé H, Okkels H, et al. Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients [J]. Pharmacogenetics, 1997, 7(1):21-25
12. Ames BN, Gold LS. Chemical carcinogenesis: too many rodent carcinogens [J]. Proc Natl Acad Sci U S A, 1990, 87(19): 7772-7776.
13. Przygodzki RM, Bennett WP, Guinee DG Jr, et al. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer [J]. Pharmacogenetics, 1998, 8(6): 503-511.
14. Krajinovic M, Labuda D, Richer C, et al. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms [J]. Blood, 1999, 93(5): 1495-1501.
15. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers [J]. Cancer Lett, 2001, 169(1):21-26.
16. Talseth BA, Meldrum C, Suchy J, et al. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients [J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(11):2307-2310.
17. Godschalk RW, Dallinga JW, Wikman H, et al. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2 [J]. Pharmacogenetics, 2001, 11(5): 389-398.
18. Gertig DM, Stampfer M, Haiman C, et al. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study [J]. Cancer Epidemiol Biomarkers Prev. 1998, 7(11): 1001-1005.
19. Slattery ML, Potter JD, Samowitz W, et al. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer [J].Cancer Epidemiol Biomarkers Prev, 1998, 7(12): 1079-1084.
20. Jahnke V, Matthias C, Fryer A, et al. Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx [J]. Am J Surg, 1996, 172(6):671-673.
21. Nazar-Stewart V, Vaughan TL, Burt RD, et al. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma [J]. Cancer Epidemiol Biomarkers Prev, 1999, 8(6):547-551.
22. Tiwawech D, Srivatanakul P, Karalak A, et al. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma [J]. Asian Pac J Cancer Prev, 2005, 6(3):270-275.
23. Moyer AM, Salavaggione OE, Hebbring SJ, et al. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics [J]. Clin Cancer Res, 2007, 13(23):7207-7216.
24. Deng ZL, Wei YP, Ma Y. Frequent genetic deletion of detoxifying enzyme GSTM1 and GSTT1 genes in nasopharyngeal carcinoma patients in Guangxi Province, China[J]. Zhonghua Zhong Liu Za Zhi, 2004, 26(10):598-600.[in Chinese]